bioRxiv Science⌕ Search

Biology subjects

Klakow, D.

Publications and source records attributed to Klakow, D..

3 recordsLinked to original sources

A data-driven rediscovery of the specificity-conferring code of adenylation domains in nonribosomal peptide synthetases

Nonribosomal peptide synthetases (NRPSs) are large modular enzymes that assemble structurally diverse peptides, many of pharmacological importance, including antibiotics and immunosuppressants. Within each NRPS module, the adenylation (A) domain selects the substrate to be incorporated, a choice governed by a small set of residues lining the binding pocket. For two decades, computational prediction of A-domain substrate specificity has relied on residue sets--most prominently the Stachelhaus code and the 34-residue "8 [A] code"--that were defined by spatial proximity to the substrate rather than by demonstrated predictive value. Here we revisit which residues govern substrate specificity from a purely data-driven perspective. We assembled a non-redundant dataset of 5,366 A-domain sequences (4,693 bacterial and 673 fungal) and used information-theoretic measures to rank alignment positions by their statistical association with substrate identity, without restricting candidate positions to any predefined structural shell. This procedure yielded two compact, kingdom-specific codes: IG15B (15 positions) for bacterial and IG13F (13 positions) for fungal A-domains. Both match or exceed the predictive accuracy of the 34-residue 8 [A] code while using fewer than half its positions, and both independently recover the majority of the classical Stachelhaus positions. Notably, our analysis identifies four positions (242, 280, 281, and 284) that lie outside all conventional codes yet carry non-redundant specificity information and co-localize with classical determinants on two helices flanking the binding pocket. These positions provide new candidate sites for the rational engineering of A-domain specificity. Author summaryMany clinically important drugs--including antibiotics such as vancomycin and immunosuppressants such as cyclosporin--are nonribosomal peptides, assembled by large enzymes known as nonribosomal peptide synthetases. These enzymes contain adenylation domains that act as molecular gatekeepers, each selecting one chemical building block to add to a growing peptide. Identifying which amino acids within a domain determine this choice is central both to predicting what an enzyme produces and to re-engineering it to make new compounds. For over twenty years, researchers have approached this question by selecting the amino acids that sit physically closest to the substrate. However, being close to the substrate does not guarantee that a residue actually influences substrate selection. In this work, we instead let the data decide: using thousands of adenylation domain sequences, we measured which positions are statistically most informative about the substrate, using information gain, mutual information and{chi} 2 statistic. We found that far fewer positions than conventionally used are sufficient to predict specificity, and--importantly--we identified several influential positions that earlier approaches had overlooked because they lie just beyond the conventional distance cutoff. These positions offer promising new targets for engineering these enzymes to produce novel peptide-based drugs.

bioinformatics↗

Generative AI designs functional thiolation domains for reprogramming non-ribosomal peptide synthetases

Large language models and generative protein design promise to accelerate biotechnology, but it remains unclear whether they can engineer dynamic megasynth(et)ases whose activity depends on transient, context-specific domain interfaces. Non-ribosomal peptide synthetases (NRPSs) are an especially demanding target, yet a high-value one because they produce many clinically important natural products and offer a route to analogs that are often difficult or impractical to access by chemical synthesis. Here we integrate pretrained generative models (ESM3, ProteinMPNN and EvoDiff) with design-build-test-learn cycles and data-guided prioritization to generate 76 de novo thiolation (T) domains. We built and tested 578 recombinant NRPS variants in vivo spanning minimal, full-length and hybrid assembly lines. AI-designed T-domains supported product formation across architectures, enabled catalytically active hybrids at recombined junctions and increased yields by up to [~]3-fold relative to NRPSs carrying the native T-domain. A representative design showed improved soluble expression, refolding, and a 12 {degrees}C higher melting temperature, while molecular dynamics simulations indicated preserved global stability but reshaped, state-dependent interdomain contact networks. Together, these results establish generative design as an effective route to context-conditioned optimization and reprogramming of biosynthetic assembly lines.

synthetic biology↗

Accelerating ligand discovery by combining Bayesian optimization with MMGBSA-based binding affinity calculations

Predicting protein-ligand binding affinity with high accuracy is critical in structure-based drug discovery. While docking methods offer computational efficiency, they often lack the precision required for reliable affinity ranking. In contrast, molecular dynamics (MD)-based approaches such as MMGBSA provide more accurate binding free energy estimates but are computationally intensive, limiting their scalability. To address this trade-off, we introduce an active learning framework that automates molecule selection for docking and MD simulations, replacing manual expert-driven decisions with a data-efficient, model-guided strategy. Our approach integrates fixed -- partly pre-trained deep learning -- molecular embeddings (MolFormer, ChemBERTa-2, and Morgan fingerprints) with adaptive regression models (e.g. Bayesian Ridge and Random Forest) to iteratively improve binding affinity predictions. We evaluate this approach retro-spectively on a new dataset of 59,356 chemically diverse compounds from ZINC-22 targeting the MCL1 protein using both AutoDock Vina and MMGBSA binding free energy scores. Our results show that incorporating MMGBSA scores into the active learning loop significantly enhances performance, recovering 79.9% of the top 1% binders in the whole dataset, compared to only 6.7% when using docking scores alone. Notably, MMGBSA exhibits a stronger correlation with experimental binding affinities than AutoDock Vina on our dataset and enables more accurate ranking of candidate compounds in a runtime efficient way. Furthermore, we demonstrate that a one-at-a-time acquisition active learning strategy consistently outperforms traditional batched acquisition, the latter achieving just 78.4% recovery with MolFormer and Bayesian Ridge. These findings underscore the potential of integrating deep learning-based molecular representations with MD-level accuracy in an active learning framework, offering a scalable and efficient path to accelerate virtual screening and improve hit identification in drug discovery.

bioinformatics↗